ACRIVON THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.89 USD | +3.86% |
|
+1.37% | +80.69% |
| 05-14 | Acrivon Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-30 | North American Morning Briefing : More Earnings -2- | DJ |
Chart calendar Acrivon Therapeutics, Inc.
d71fce7574586fb.rlRK6YNmJbgnu4574xBNlRJUJ4LAoqfk2oU_VX50THE.yQwQissRbo1t3_0-s1Vg9HYcRLXwj9GxibAPeAYZAwnaOAOe0gdpwmbLyw~8e89da60b5148a59f446f850ed612ea1
Upcoming events on Acrivon Therapeutics, Inc.
Past events on Acrivon Therapeutics, Inc.
| 14/05/2024 13:00 | Q1 2024 Earnings Release |
| 24/04/2024 21:15 | R&D Day |
| 09/04/2024 17:00 | American Association for Cancer Research Meeting - Abstract Number :- 4749 |
| 08/04/2024 17:00 | American Association for Cancer Research Meeting - Abstract Number :- 1977 |
| 28/03/2024 12:00 | Q4 2023 Earnings Release |
| 05/03/2024 15:30 | TD Cowen Health Care Conference |
| 13/02/2024 19:40 | Oppenheimer Healthcare Life Sciences Conference |
| 11/01/2024 19:15 | JPMorgan Healthcare Conference |
| 28/11/2023 13:30 | Piper Sandler Healthcare Conference |
| 09/11/2023 13:01 | Q3 2023 Earnings Release |
| 14/10/2023 17:30 | AACR-NCI-EORTC International Conference - Poster No: C002 |
| 13/10/2023 17:30 | AACR-NCI-EORTC International Conference - Poster No: B012 |
| 07/09/2023 20:45 | Wells Fargo Healthcare Conference |
| 05/09/2023 | Citi BioPharma Conference |
| 11/08/2023 12:00 | Q2 2023 Earnings Release |
| 22/06/2023 17:30 | Annual General Meeting |
| 08/06/2023 13:00 | Jefferies Global Healthcare Conference |
| 09/05/2023 13:00 | Q1 2023 Earnings Release |
| 02/05/2023 20:00 | H.C. Wainwright BioConnect Investor Conference |
| 01/05/2023 16:00 | Investor Meeting |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -32,7 -39,7 17.74% | -67,1 -62,7 -7.04% | -79,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -31,2 -33,0 5.67% | -60,4 -58,3 -3.61% | -77,0 |
|
Net income Million USD | Released Forecast Spread | -16,2 | -31,2 -33,0 5.67% | -60,4 -58,3 -3.61% | -77,0 |
|
EPS USD | Released Forecast Spread | -3,78 | -7,56 -7,64 1.05% | -2,74 -2,63 -4.38% | -2,52 |
| Announcement Date | 12/08/22 | 28/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -9,58 -10,0 4.25% | -9,95 -17,0 41.5% | -14,4 -13,5 -6.63% | -15,5 -15,6 0.39% | -16,1 -16,5 2.44% | -21,1 -17,0 -23.97% | -17,7 -21,0 15.71% | -20,0 | -20,4 | -21,0 | -23,5 | -24,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,20 -7,00 -31.4% | -8,93 -13,0 31.32% | -12,8 -12,3 -3.71% | -13,9 -14,1 1.59% | -14,5 -15,8 8.35% | -19,3 -16,5 -16.41% | -16,5 -19,8 16.86% | -20,2 | -21,1 | -21,8 | -23,5 | -24,0 |
|
Net income Million USD | Released Forecast Spread | -9,20 -7,00 -31.4% | -8,93 -13,0 31.32% | -12,8 -12,3 -3.71% | -13,9 -14,1 1.59% | -14,5 -15,8 8.35% | -19,3 -16,5 -16.41% | -16,5 -19,8 16.86% | -20,2 | -21,1 | -21,8 | -23,5 | -24,0 |
|
EPS USD | Released Forecast Spread | -5,17 -3,95 -30.89% | -0,80 -1,38 42.03% | -0,58 -0,63 8.3% | -0,63 -0,64 2.07% | -0,66 -0,72 7.69% | -0,87 -0,73 -20% | -0,73 -0,84 13.35% | -0,60 | -0,57 | -0,57 | -0,67 | -0,70 |
| Announcement Date | 15/12/22 | 28/03/23 | 09/05/23 | 11/08/23 | 09/11/23 | 28/03/24 | 14/05/24 | - | - | - | - | - |
| 20/05/2024 | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 21/05/2024 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
| 21/05/2024 | EVOTEC SE: Q1 2024 Earnings Release |
| 30/06/2024 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Acrivon Therapeutics, Inc.
| Today 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 15/05/2024 21:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 14/05/2024 21:05 | NUVATION BIO INC.: Q1 2024 Earnings Release |
| 14/05/2024 12:30 | ABSCI CORPORATION: Q1 2024 Earnings Release |
| 14/05/2024 06:50 | BELITE BIO, INC: Q1 2024 Earnings Release |
| 13/05/2024 | POLARIS GROUP: Q1 2024 Earnings Release |
| 13/05/2024 21:30 | AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 13/05/2024 12:00 | APOGEE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 13/05/2024 00:00 | PRAXIS PRECISION MEDICINES, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ACRV Stock
- Calendar Acrivon Therapeutics, Inc.
